Acusensus's Days Sales Outstanding for the
six
months ended in Dec. 2025 was 41.52.
Acusensus's Days Inventory for the
six
months ended in Dec. 2025 was 13.72.
Acusensus's Days Payable for the
six
months ended in Dec. 2025 was 46.73.
Therefore, Acusensus's Cash Conversion Cycle (CCC) for the
six
months ended in Dec. 2025 was 8.51.
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Acusensus Cash Conversion Cycle Related Terms
Acusensus Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Acusensus's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:ACE vs MSFT, ORCL, PLTR: Cash Conversion Cycle Comparison
For the Software - Infrastructure subindustry, Acusensus's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acusensus Cash Conversion Cycle vs Software Industry
For the Software industry and Technology sector, Acusensus's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Acusensus's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Acusensus's Cash Conversion Cycle for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acusensus (ASX:ACE) has a Cash Conversion Cycle of 8.51 as of Dec. 2025. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Acusensus and its competitors.
Is Acusensus' Cash Conversion Cycle too high?
Acusensus' current Cash Conversion Cycle is 8.51. The Software industry median Cash Conversion Cycle is 32.39. Acusensus' value of 8.51 is 73.7% below this industry median. Overall, Acusensus has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acusensus' Cash Conversion Cycle compare to MSFT and ORCL?
Acusensus' Cash Conversion Cycle of 8.51 can be compared against companies in the Software industry. The industry median Cash Conversion Cycle is 32.39. Acusensus' value of 8.51 is 73.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Software company?
The median Cash Conversion Cycle among Software companies is 32.39, based on 2,805 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acusensus's current Cash Conversion Cycle of 8.51 is 73.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Acusensus and its competitors. For the Software industry, the median Cash Conversion Cycle is 32.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acusensus's current Cash Conversion Cycle is 8.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acusensus stock overvalued right now?
Based on GuruFocus' analysis, Acusensus (ASX:ACE) is currently considered Modestly Undervalued. The stock's GF Value™ is A$1.47, compared to a current price of A$1.19 — trading 19.4% below its estimated fair value. The current Cash Conversion Cycle is 8.51 and 73.7% below the Software industry median of 32.39. Acusensus' overall GF Score™ is 59/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Acusensus (ASX:ACE), the current Cash Conversion Cycle is 8.51 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acusensus (ASX:ACE) Overvalued in 2026?
Based on GuruFocus' analysis, Acusensus stock appears to be undervalued.
The current stock price of A$1.19 is trading 19.4% below its estimated GF Value™ of A$1.47.
GuruFocus considers Acusensus to be Modestly Undervalued.
Key valuation signals for ASX:ACE:
Cash Conversion Cycle: 8.51
GF Value™: A$1.47 vs. price of A$1.19 (19.4% below fair value)
Industry Position: 73.7% below the Software median
No single metric tells the full story. See the ASX:ACE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acusensus Ltd is involved in developing and commercializing intelligent traffic solutions technology. Its 'Heads-Up' solution has been designed to give authorities a tool to address distraction and other illegal driver behavior, to drive behavioral change on the road network. It also provides Data security solutions. The company's main objective is to Pioneer intelligent solutions to tackle difficult societal challenges, reduce road trauma and save lives. Geographically the company generates the majority of its revenue from Australia.
59GF Score
Get the complete analysis for ASX:ACE
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ACE has been successfully added to your 